Overview

Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The study hypothesis: Valsartan as an angiotensin II receptor blocker treatment has beneficial effects on both midwall mechanics and myocardial functions in hypertensive patients with Left ventricular hypertrophy.
Phase:
Phase 4
Details
Lead Sponsor:
Mustafa Kemal University
Collaborator:
Novartis Pharmaceuticals
Treatments:
Valsartan